Year-End Information Quality Report
[ HHS Information Quality
Main Page ]
I.
Cover Sheet: Requests for Correction by Agency
Department Name: Department of Health and Human Services
Period Covered: October 2002 through September 2003
Web page location of agency information quality correspondence: http://aspe.hhs.gov/infoquality/requests .shtml
Agency Name |
Number of
Requests Received |
Number Designated
as Influential* |
FDA |
2 |
|
NIH |
7 |
|
OPHS |
1 |
|
TOTALS |
10 |
1 |
* Does not include information quality requests currently beeing reviewed due
to a request for reconsideration
II.
If you received correction requests or appeals and did not provide a final response in FY03, please
list those correction requests below and provide a detailed summary in Section III ofthis template.
Agency Name |
Number of FY03 Requests
Responded to in 04 |
Number of FY03 Appeals
Responded to in 04* |
NIH |
|
1 |
|
|
|
OPHS |
|
1 |
TOTALS |
0 |
2 |
* See Sections III. 3 and 11.
III.
Template
1.
- Agency Receiving Correction Request: Department of Health and Human Services, Food and Drug Administration
- Requestor: Environmental Working Group (EWG), an advocacy group
- Date Received: Letter dated December 22,2003, delivered by u.S. Postal Mail and logged in by the Office ofthe Ombudsman, FDA on January 5, 2004.
- Summary of Request: EWA requests correction of the 2003 FDA Consumption Draft Advisory
regarding the risks of mercury contaminated fish and shellfish, specifically
entitled "Advice For Women Who Are Pregnant, Who Might Become Pregnant,
And Nursing Mothers, About A voiding Harm To Your Baby Or Young Child From
Mercury In Fish And Shellfish."
- Description of Requested Correction: EWG recommended the following:
1) FDA should conduct an updated, comprehensive sampling program for seafood.
2) FDA should provide consumption advice that consumers can follow without
appreciable risk to their health.
3) FDA should provide specific advice on how much seafood young children can safely consume.
4) FDA should provide specific advice on canned tuna.
5) Calculation of risk on "exceedences" of the reference dose for the last half of the
third trimester of pregnancy should be consistent with interpretations
of the National Academy of Sciences 2000 report.
6) FDA should develop and make public documentation of a scientific assessment
conducted in correcting the 2003 Advisory.
- Influential: ___Yes ___No ___ Undetermined _X_ Under Appeal
- First Agency Response: _X_ in progress* ___ completed
* The response was sent on February 15, 2005
- Resolution:
- Appeal Request: ___ none ___ in progress _X_ completed
- Judicial Review:
- Summary of Request for Reconsideration:
- Type of Appeal Process Used:
- Appeal Resolution
2.
- Agency Receiving Correction Request: Department of Health and Human Services, Food and Drug Administration
- Requestor: Buc & Beardsley, a law firm on behalf of their client, McNeil Consumer & Specialty Products.
- Date Received:Letter dated May 18, 2004, logged in by the Office of the Ombudsman, FDA on May 19,2004.
- Summary of Request: The request concerns FDA's
"Consumer Campaign on Safe Use of OTC Pain Products." The request
maintains that the campaign misrepresents the relative safety of various OTC pain
products by suggesting that acetaminophen products are less safe than nonsteroidal
anti-inflammatory drugs (NSAIDs).
- Description of Requested Correction:The
complainant requests the following: (1) FDA should halt distribution of the
current campaign which consists of advertisements entitled"Why is it
important to know that all these medicines contain acetaminophen?" and
"The best way to take your over-the-counter pain reliever?
Seriously;" an article in the FDA Consumer magazine, a memo to State Boards
of Pharmacy on this issue, "Questions and Answers on Using Over-theCounter
Human Drug Products Containing Analgesic/Antipyretic Active Ingredients
Safely;" and a brochure entitled, "The best way to take your
over-thecounter pain reliever? Seriously," (2) FDA should correct the
relevant documents before restarting the campaign, and (3) FDA should provide
an opportunity for McNeil and other companies whose products are affected to
comment prior to restarting the campaign and prior to the release of any
future OTC pain relief drug campaigns.
- Influential: ___Yes _X_ No ___Undetermined
- First Agency Response: ___ in progress _X_completed
FDA responded on August 25, 2004
- Resolution:The FDA did not agree that the
campaign violates the Data Quality Act or Guidelines. Based on suggestions
from the Nonprescription Drug Advisory Committee, which met on Sept. 19-20,
2002, the educational campaign was developed in accordance with agency policies
and procedures. The documents were developed by a team of experts familiar
with the drugs and communication specialists, it was focus group tested with
the public, circulated and cleared by senior leaders within the FDA as well
as by the Office ofthe Secretary of the Department of Health and Human
Services.
- Appeal Request:* ___ none ___ in progress ___ completed.
- Judicial Review:
- Summary of Request for Reconsideration:
- Type of Appeal Process Used:
- Appeal Resolution:
* In fiscal year 2005 (October 22, 2004), an electronic version of a request for
"Reconsideration of Complaint and Request for Correction to Federal Data
Quality Act Concerning "Consumer Campaign on Safe Use ofOTC Pain
Products" was received by the FDA's Office ofthe Ombudsman
3.
4.
- Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health, National Institute on Aging
- Requestor:
Ken Boehm, Chairman
National Legal and Policy Center
Public Interest Group
- Date Received:
March 16,2004 received March 17,2004 by U.S. mail
- Summary of
Request: The requestor challenged information regarding the risks of using
smokeless tobacco as compared to smoking cigarettes. The requestor maintained
that the statement that smokeless tobacco is not safer than cigarettes is
erroneous and not supported by sound scientific evidence. According to the
requestor, there is a scientific consensus that the use of smokeless tobacco
involves significantly fewer risks of adverse health effects than cigarette
smoking.
- Description
of Requested Correction: The requestor asked that the agency delete the
heading and paragraph containing the challenged information and substitute
language that smokeless tobacco "is significantly less hazardous than
smoking" and that there are "significantly less risk of adverse
health effects" associated with using smokeless tobacco as compared to
smoking cigarettes.
- Influential: ___ Yes _x_ No ___ Undetermined
- First Agency
Response: ___ in progress _X_ completed June 29, 2004
- Resolution:
The agency did not accept the requestor's suggested language but did agree to
update the challenged language based on the current scientific literature.
The revised language notes that smokeless tobacco products "are not
safe" and describes the risks associated with using such products
without making an affirmative comparison of those risks to the risks
associated with smoking cigarettes.
- Appeal Request: _X_ none ___ in progress ___ completed
- Judicial
Review: _X_ none
- Summary of Request
for Reconsideration:
- Type of
Appeal Process Used:
- Appeal
Resolution:
5.
-
Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health, Office of the Director
- Requestor:
Jerry A. Cook
Chemical Products Corporation
Corporation
- Date
Received: Request received February 6, 2004 by electronic submission
- Summary of
Request: The requestor challenged the information posted electronically in
draft Technical Report (TR494) regarding toxicity and carcinogenicity studies
of anthraquinone. The requestor claimed the draft TR494 lacked
"transparency and objectivity" and contained incomplete information
necessary to evaluate the effects of anthraquinone.
- Description
of Requested Correction: The requester asked that Draft TR494 be withdrawn
and completely revised.
- Influential: ___ Yes _X_ No ___ Undetermined
- First Agency
Response: ___ in progress _x_ completed July 16,2004
- Resolution:
NIH determined that the agency's Guidelines were not applicable to the
request because the challenge concerned a draft report, not a final
statement representing the views of the NIH. In addition, because the draft
report at issue was subject to notice and public comment, these
procedures were the appropriate mechanism forconsidering the
requestor's comments on the draft TR494. Accordingly, the agency included the
requestor's submission in the public comment process.
- Appeal
Request: ___ none _X_ in progress ___ completed
- Judicial
Review: _X_ none
- Summary of
Request for Reconsideration: The requestor maintains that although TR494 was
a draft, the underlying scientific information contained in the draft was not
and must be clear and accurate in order for public comment and peer
review to be effective. According to the requestor, the alternative process
of public comment and peer review will be flawed ifthe draft is not subject
to the processes set forth in the Information Quality Guidelines.
- Type of
Appeal Process Used: Senior Official Review
- Appeal
Resolution: N/A - Request for Reconsideration is pending
6.
- Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health (NIH), National Institute of Environmental
Health Science (NIEHS), National Toxicology Program (NTP)
- Requestor:
The Nickel Development Institute (NiDi),
The NickelProducers Environment Research Association (NiPERA), and
Inco, United States
Neil J. King, Lawyer
Wilmer, Cutler & Pickering
- Date
Received: The request was dated 4/9/03 and received electronically on
4/18/03.
- Summary of
Request: The request maintains that discussion in the 10th Report on
Carcinogens (RoC) listings of Nickel Compounds and Metallic Nickel does not
comply with the OMB Guidelines or with the HHS and NIH Guidelines in the
following respects:
1) It does not comply with the 'objectivity'
requirement of the OMB Guidelines because: A) It is not 'presented in an
accurate, clear, complete and unbiased manner'; and B) It does not present
'accurate, reliable, and unbiased information. '
2) Although the 10th RoC presents' influential'
scientific information relating to an analysis of risks to human health
allegedly posed by exposure to nickel compounds and metallic nickel, it fails
to comply with the scientific quality principles established by Congress in
the Safe Drinking Water Act Amendments of 1996, as required by the OMB
Guidelines, in that: A) It does not use the best available peer reviewed
science; B) It does not identify studies that fail to support the
carcinogenic effect; and C) It is not comprehensive, informative, and
understandable.
- Description
of Requested Correction: "NiDi, NiPERA, and lnco request that the
material identified in the request be corrected (as indicated herein) and
that an appropriately revised discussion of Nickel Compounds and Metallic
Nickel be published and disseminated as a correction to the 10th RoC."
- Influential: ___ Yes _X_ No ___Undetermined/Unsure
- First Agency Response: ___in progress _X_ completed. The NTP response was sent by mail on
10/24/03.
- Appeal
Request: ___ none ___ in progress _X_completed. The NTP received the appeal dated
November 17, 2003, by electronic mail on December 9, 2003 from NIH. The
appeal response was sent October 27,2004.
- Summary of
Request for Reconsideration: The Petitioner claims that "the lOth RoC's
discussion of Nickel Compounds and Metallic Nickel fails to comply with
requirements of the Data Quality Act, as implemented in the OMB, HHS, and NIH
Guidelines." The request asks that the "appeal of NTP's denial of
my April 9, 2003 request for correction of information be granted," the
issues identified the April 9, 2003 letter be
corrected in the profiles of Nickel Compounds and Metallic Nickel in the 1
Oth RoC, and the revised profile "be published and disseminated as a
correction to the 10th RoC."
- Type of Appeal Process Used: Senior
Official Review
- Appeal Resolution:
(Completed in FY 2005)
7.
- Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health (NIH), National Institute of Environmental
Health Science (NIEHS), National Toxicology Program (NTP)
- Requestor:
Vinyl
Chloride Health Committee
American Chemistry Council
Courtney M. Price
Vice
President, CHEMSTAR
- Date
Received: The request was dated July 1,2004 and received by electronic mail
on July 7, 2004.
- Summary of
Request: The request asks for the correction of information in the profile
for vinyl chloride in the 11th and future editions of the Report on
Carcinogens.
- Description
of Requested Correction: The requestor asks that the NTP delete information
in the carcinogenicity section of the profile for vinyl chloride.
- Influential: ___ Yes _X_ No ___ Undetermined
- First Agency
Response: ___ none _X_ in progress ___ completed
- Resolution:
- Appeal
Request: ___ in progress ____completed
- Judicial Review:
- Summary of
Request for Reconsideration:
- Type of
Appeal Process Used:
- Appeal
Resolution:
8.
- Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health (NIH), National Institute of Environmental
Health Science (NIEHS), National Toxicology Program (NTP)
- Requestor:
Jim 1. Tozzi
Center for
Regulatory Effectiveness
Jere White
Kansas Corn
Growers Association Garry Marshall
Missouri
Corn Growers Association Stephanie Whalen
Hawaii
Agriculture Research Center Joel Nelsen
California
Citrus Mutual
- Date
Received: The request was dated July 16,2004 and received by electronic mail
on July 19,2004.
- Summary of
Request: The request maintains that the information about atrazine and cancer
published by the NTP in the Federal Register (69 FR 28940) is
misleading and incomplete. The notice announces the NTP's intent to consider
review of atrazine for possible listing in the 12th Report on
Carcinogens and gives the basis for the nomination. The request states that
the notice should provide additional background about ongoing studies of
atrazine and details about reviews by other scientific panels.
- Description
of Requested Correction: The requestor asks that the NTP correct information
in NTP's Federal Register notice that pertains to atrazine and
withdraw that part of the notice that addresses review of atrazine in the 12th Report on Carcinogens.
- Influential: ___ Yest _X_ No ___ Undetermined
- First Agency
Response: _X_in progress ___ completed
- Resolution:
- Appeal
Request: ___ in progress ___ completed
- Judicial
Review:
- Summary of
Request for Reconsideration:
- Type of
Appeal Process Used:
- Appeal
Resolution:
9.
- Agency
Receiving Correction Request: Department of Health and Human Services,
National Institutes of Health (NIH), National Institute of Environmental
Health Science (NIEHS), National Toxicology Program (NTP)
- Requestor:
Jim J. Tozzi
Center for
Regulatory Effectiveness
Jere White
Kansas Corn
Growers Association
Garry
Marshall
Missouri
Corn Growers Association Stephanie Whalen
Hawaii
Agriculture Research Center
Greg Shelor
Kansas Grain
Sorghum Products Association
Joel Nelsen
California
Citrus Mutual
- Date
Received: The request was dated June 28, 2004 and received by electronic mail
on July 1,2004.
- Summary of
Request: The request maintains that the NTP published in the Federal
Register (69 FR 28940) conflicting information about the procedures that
will be used for review of nominations to the 12th Report on Carcinogens.
- Description
of Requested Correction: The requestor asks that the NTP withdraw the Federal
Register notice (69 FR 28940) and not publish another notice until the
program decides what procedures will apply for review of nominations to the
12th Report on Carcinogens and publishes them as final.
- Influential: ___ Yes ___No ___ Undetermined
- First Agency
Response: _X_in progress ___ completed
- Resolution:
- Appeal
Request: ___ none ___ in progress ___ completed
- Judicial
Review:
- Summary of
Request for Reconsideration:
- Type of
Appeal Process Used:
- Appeal
Resolution:
10.
- Agency Receiving Correction Request: Department
of Health and Human Services, National Institutes of Health (NIH), National
Institute of Environmental Health Science (NIEHS), National Toxicology
Program (NTP)
- Requestor:
Naphthalene Panel
American Chemistry Council
Courtney M. Price
Vice President, CHEMST AR
- Date
Received: The request was dated July 1,2004 and received by electronic mail
on April I, 2004.
- Summary of
Request: The request asks that I) the NTP correct three documents: the
Background Document for Naphthalene and Summaries of the NIEHS/NTP Review
Group I and NTP Executive Committee Interagency Working Group (RG2) for the
Report on Carcinogens (RoC) meetings, 2) the NTP rescind the meetings of the
RG2 and the NTP Board of Scientific Counselors RoC Subcommittee and hold new
meetings of both groups. 3) As an alternative, the request asks that the NTP
staff, NIH's Office of Communications and Public Liaison (OPCL), and the NTP
Executive Committee "undertake a comprehensive pre-dissemination review
ofthe entire record of the listing proceeding as it relates to naphthalene
before any recommendation is made concerning listing naphthalene in the Eleventh
RoC by the NTP Director."
- Description
of Requested Correction: The request states that "[t]he best and only
appropriate solution to these violations is for the NTP to rescind the
November 19, 2002, vote
of the RoC Subcommittee on the listing of naphthalene, rescind the RG2 review
summary, withdraw the Background Document from the NTP's website and
otherwise cease dissemination of that document, correct the Background
Document so that it comports with the OMB, NIH, and HHS Guidelines, make the
corrected document
publicly available, and arrange for repeats of the RG2 and NTP RoC
Subcommittee meetings that comport with the OMB, NIH, and HHS Guidelines, to
be held after issuance of the corrected Background Document. NTP should also
correct the RG I and, if not rescinded, the RG2 review summaries to provide
the necessary detail to satisfy the objectivity and utility
requirements."
"Alternatively,
if this remedy is not granted, the Panel requests that NTP staff, NIH's OPCL,
and the NTP Executive Committee engage in a well-defined process of
pre-dissemination review of the entire naphthalene record with regard to the
data quality standards under the NIH, OMB, and HHS Guidelines before the NTP
Executive Committee makes its recommendation to the NTP Director."
- Influential: ___Yes ___No ___ Undetermined _X_ Under Appeal
- First Agency
Response: _X_in progress* ___ completed
The response was sent on January 18, 2005
- Resolution:
- Appeal Request: ___ none ___ in
progress ___ Completed
- Judicial
Review:
- Summary of
Request for Reconsideration:
- Type of
Appeal Process Used:
- Appeal
Resolution:
11.
12.
- Agency Receiving Correction Request:
U.S.
Department of Health and Human Services, Office of Public Health and Science,
Office of Disease Prevention and Health Promotion
- Requestor: A
Private Citizen
- Date
Received: Letter sent by postal mail dated July 14, 2004 and logged in on
July 26,2004
- Summary of
Request: The requestor states that, as of the date of his letter, the
organizations and Web sites in healthfinder@ pertaining to complementary and
alternative medicine do not meet the published healthfinder@ selection
criteria.
- Description
of Requested Correction: The request seeks the de-listing from healthfinder@
of the complementary and alternative medicine organizations and Web sites
identified by the requestor in his letter as not meeting healthfinder@
selection standards, and the inclusion of other sites identified by the
requestor as meeting the standards
- Influential: ___ Yes _X_ No ___ Undetermined
- First Agency
Response: _X_in progress ___ Completed<
- Resolution
- Appeal
Request: ___ none ___ in progress ___ completed
- Judicial
Review:
- Summary of
Request for Reconsideration
- Type of Appeal
Process Used
- Appeal
Resolution
Notes:
1. Because the standard for review in a motion to
dismiss construes the complaint in the light most favorable to plaintiffs,
the Court accepted plaintiffs' assertion that the available publications do
not contain all the data sought and, therefore, it rejected HHS' argument
that the complaint is moot. Opinion ("Op.") at 15.
2.The Court also ruled that plaintiffs do not have
"organizational standing." Organizational standing may arise when
members of an organization suffer an injury in fact that would give the
individuals standing to sue on their own behalf. The Court dismissed this
theory because plaintiffs did not properly allege it, a finding that may be
read by some to allow that organizational standing may arise in a case with
different facts.
3 3.Thus, this case stands firmly for the proposition
that IQA challenges to "informal" agency information are not subject to judicial review, but it might be read
to allow review of "formal" agency information, like a rulemaking.
In its briefing, HHS acknowledged that formal agency actions might be
considered differently, but it did not reach a conclusion. Whether an IQA
challenge to a rulemaking under the APA can survive if it is lacks separately
permissible challenges, e.g., of arbitrary and capricious reasoning, will
need to be considered carefully.